M3, Inc. (TYO:2413)

Revenue

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014
Medical Platform Segment Revenue	107.83B	91.57B
Medical Platform Segment Revenue Growth	17.76%	-1.98%
Evidence Solution Segment Revenue	24.52B	24.24B
Evidence Solution Segment Revenue Growth	1.14%	-9.20%
Career Solution Segment Revenue	22.80B	20.91B
Career Solution Segment Revenue Growth	9.01%	25.67%
Site Solution Segment Revenue	54.35B	47.04B
Site Solution Segment Revenue Growth	15.54%	42.45%
Patient Solution Segment Revenue	56.88B	21.92B
Patient Solution Segment Revenue Growth	159.49%	-
Overseas Segment Revenue	86.92B	80.57B
Overseas Segment Revenue Growth	7.88%	15.32%
Other Emerging Businesses Segment Revenue	2.23B	2.45B
Other Emerging Businesses Segment Revenue Growth	-9.09%	-6.84%
Adjustments to Segment Revenue	-4.17B	-3.81B

EBIT

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014
Medical Platform Segment Profit	35.92B	34.11B
Medical Platform Segment Profit Growth	5.32%	-11.71%
Evidence Solution Segment Profit	5.12B	4.35B
Evidence Solution Segment Profit Growth	17.84%	-35.13%
Career Solution Segment Profit	5.93B	5.66B
Career Solution Segment Profit Growth	4.76%	18.30%
Site Solution Segment Profit	5.77B	5.42B
Site Solution Segment Profit Growth	6.35%	45.17%
Patient Solution Segment Profit	2.69B	824.00M
Patient Solution Segment Profit Growth	225.97%	-
Overseas Segment Profit	14.90B	14.75B
Overseas Segment Profit Growth	1.04%	26.08%
Other Emerging Businesses Segment Profit	4.88B	1.00B
Other Emerging Businesses Segment Profit Growth	386.34%	-
Adjustments to Segment Profit	-1.64B	-3.13B

Key Performance Indicators

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014
Number of Medical Institutions Using M3 DigiKar	9.60K	7.70K
Number of Medical Institutions Using M3 DigiKar Growth	24.68%	25.20%

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 2, 2026

Data Sources Report a data error